Skip to content
CPSH

CPS TECHNOLOGIES CORP/DE/

CPS TECHNOLOGIES CORP/DE/ Q1 FY2024 earnings call

May 2, 2024 · fiscal period ended 2024-03

EPS · actual vs est

/

Revenue · actual vs est

/
Ask about this call

Summary

Generated 2024-05-02

Management highlights

  • The company invested in additional engineering and material science personnel, with 3 more salaried employees than Q1 2023, including a lead for new product introduction. - Completed and shipped 8 new first articles in Q1, up from 2 in the prior year; these first articles are new parts that could lead to future production runs. - Entered a manufacturing licensing agreement with Triton Systems for fiber reinforced aluminum composites (FRA), with manufacturing trials for FRA to start later in the quarter. - Received $200,000 from the Massachusetts Manufacturing Accelerate program to purchase a 5-axis CNC machine, expanding manufacturing capabilities. - Achieved success in a SBIR Phase I program for modular radiation shielding, with a Phase II proposal submitted; results presented at Idaho National Laboratory.
View in transcript ↓

Segment performance

Revenue for the first quarter was $5.9 million, down from $7.1 million in the prior year. Gross profit totaled $0.9 million, approximately 15.3% of sales, compared to $2.2 million or 31.6% of sales in the prior year. The decline in revenue and gross profit was due to production constraints from quality control testing, labor shortages, and inefficiencies.

View in transcript ↓

Guidance

  • Anticipate gross margins to improve in the second half of 2024. - Acknowledge headwinds from the anticipated drop-off in near-term ARMOR revenue. - Expect the financial return from new personnel to take time to develop. - Manufacturing trials for FRA composites to start later in the quarter.
View in transcript ↓

Risks

  • Uncertainties from geopolitical events (e.g., wars in Ukraine and Israel), economic conditions, market demands, and competitive factors. - Labor shortages and turnover that impacted production and margins in Q1. - Timing uncertainties related to SBIR Phase II funding and market entry of new products like FRA composites.
View in transcript ↓

Q&A highlights

Q: What's the first product likely to generate near-term revenue?

A: Hermetic packaging using the newly acquired 5-axis CNC machine; once in-house capability is established, it will allow cost-competitive pricing for first articles that could lead to volume orders.

Q: Labor situation in the long term?

A: It was a temporary issue in Q1; currently, the company is fully staffed for future production, but could reappear if needing to hire a large number of people.

Q: How does the shielding work compare cost-wise to current solutions?

A: The shielding solution reduces weight and material usage, providing benefits for mobile applications (e.g., transiting micro reactors) and stationary applications (e.g., building construction) due to lower weight requirements.

Q: Status of Armor revenue?

A: Down from prior year, but not gone yet; there are ongoing conversations for future Armor opportunities, though it's lumpy.

Q: Details on the 5-axis tool award?

A: The $200,000 award from the Massachusetts Manufacturing Accelerate program is not a loan; it's to expand manufacturing capabilities and is being used to purchase a 5-axis CNC machine.

Q: Testing constraints status?

A: It's a temporary situation; the company is moving towards resolving testing issues, with expectation to put the testing constraints behind soon as they get close to resolving the quality problems.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS
Revenue

Transcript

May 2, 2024

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.